RNA, U6 small nuclear 1213, pseudogene (RNU6-1213P)

RNU6-1213P is a processed pseudogene originating from the reverse transcription and integration of U6 small nuclear RNA sequences with retrotransposons like LINE-1, often resulting in chimeric genomic insertions[1][7]. The parental U6 small nuclear RNA (snRNA) molecule plays a central role in spliceosome assembly and catalysis of pre-mRNA splicing, but the pseudogene itself does not participate in biological functions, encode a protein, or serve as a therapeutic target[5][7]. Pseudogenes such as RNU6-1213P are often regarded as genomic fossils or markers of retrotransposition dynamics, and their presence may reflect genome evolution rather than active biological roles[7]. There is no evidence that RNU6-1213P is a receptor, enzyme, transporter, or otherwise considered a target for drugs or therapeutic intervention[1][2][7]. If structured target data are required for therapeutic or drug discovery purposes, RNU6-1213P should be excluded, as its classification and function do not match canonical drug targets.

Other names

RNU6-1213PRNA, U6 small nuclear 1213, pseudogene

None known for the pseudogene; unrelated to drug action